Iowa

Iowa

State Facts

171

Deaths or 40.2% of total overdose deaths involved opioids in 2024.¹

572,611

Claims, or 3.38% of all Medicare Part D claims were for opioids in 2022 – an average of 45 per prescriber.²

34.6

Opioid Prescriptions were written for every 100 persons in Iowa in 2023.³

5,271

Beneficiaries on Medicare Part D had Opioid Use Disorder in 2022.⁴

Download FactSheet

Opioid Settlement Funds

$316,447,891.29
State Spending Recommendation

National approved use: providing support for non-opioid pain treatment alternatives, including training providers to offer or refer to multi-modal, evidence-informed treatment of pain.

Member & Endorser Footprint

Voices is backed by a broad coalition of organizations across the state united by a shared goal: ensuring patients have access to safe, effective, 
and individualized pain management throughout the continuum of care.

Co-Sponsors (119th)

Rep. Mariannette Miller-Meeks (R-IA-1)

Rep. Mariannette Miller-Meeks (R-IA-1)

2025 Introduced Relevant Legislation

HSB 151

This legislation requires Medicaid and commercial health insurance pplans to cover non-opioid pain treatments on equal terms with opioids. The bill prohibits disadvantaging or discouraging the use of non-opioid treatments relative to opioids and guarantees immediate coverage upon FDA
approval.

Introduced
02/11/2025
Plan Impact
Medicaid & Commercial
Learn More

1. Centers for Disease Control and Prevention (2025). Provisional Drug Overdose Death Counts. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm

2. Centers for Disease Control and Prevention (2024). Medicare Part D Opioid Prescribing Mapping Tool. https://cms-oeda.maps.arcgis.com/apps/MapSeries/index.html?appid=5390718d875d4c049b1ac5976a9ff083

3. Center for Disease Control and Prevention (2024). Opioid Dispensing Rate Maps. https://www.cdc.gov/overdose-prevention/data-research/facts-stats/opioid-dispensing-rate-maps.html

4. Office of the Inspector General (2023). The Consistently Low Percentage of Medicare Enrollees Receiving Medication to Treat Their Opioid Use Disorder Remains a Concern. https://oig.hhs.gov/documents/evaluation/2722/OEI-02-23-00250-Complete%20Report.pdf